Bioventix Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Bioventix PLC is a biotechnology company specializing in the development and supply of high-affinity monoclonal antibodies. These antibodies are used in blood testing and clinical diagnostics for applications such as hormone detection, drug testing, and disease diagnosis. The company focuses on developing antibodies for use in immunoassays, which are employed by global diagnostic companies in laboratory and point-of-care settings. The company is headquartered in Southampton, United Kingdom, and its shares are listed on the London Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BVXP
Country
🇬🇧 United Kingdom